@article{TLCR20237,
author = {Hildegard M. Schuller},
title = {Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) is a family of cancers comprised of four different histological subtypes: adenocarcinoma, squamous cell carcinoma, large cell carcinoma and carcinoids. Among the NSCLC subtypes, adenocarcinoma is the most common with incidence rising (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/20237}
}